• 1. Dissociative electron attachment to HGaF4 Lewis–Br?nsted superacid
  Marcin Czapla,Jack Simons Phys. Chem. Chem. Phys., 2018,20, 21739-21745
• 2. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
• 3. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 4. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 5. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Triazines Triazinethiones

Introduction to 5-(5-Methyl-2-furyl)-1,2,4-triazine-3-thiol (CAS No. 1142199-96-9)

5-(5-Methyl-2-furyl)-1,2,4-triazine-3-thiol is a heterocyclic compound characterized by its unique structural framework, which combines a triazine core with a furyl substituent and a thiol functional group. This compound has garnered significant attention in the field of chemical biology and pharmaceutical research due to its potential applications in drug discovery and molecular recognition. The CAS number 1142199-96-9 provides a unique identifier for this substance, facilitating its accurate classification and referencing in scientific literature.

The molecular structure of 5-(5-Methyl-2-furyl)-1,2,4-triazine-3-thiol encompasses a triazine ring system substituted with a 5-methylfuryl group at the 5-position and a thiol (-SH) moiety at the 3-position. The presence of these functional groups imparts distinct chemical properties that make the compound a versatile scaffold for further derivatization and exploration. The triazine ring is known for its ability to participate in hydrogen bonding and metal coordination, while the furyl group introduces electronic and steric effects that can influence binding interactions.

Recent advancements in computational chemistry have enabled researchers to predict the binding affinities and interactions of 5-(5-Methyl-2-furyl)-1,2,4-triazine-3-thiol with various biological targets. Studies suggest that this compound may exhibit inhibitory activity against certain enzymes and receptors, making it a promising candidate for therapeutic development. For instance, computational modeling has indicated potential interactions with enzymes involved in metabolic pathways, which could lead to applications in managing metabolic disorders.

The thiol group in 5-(5-Methyl-2-furyl)-1,2,4-triazine-3-thiol is particularly noteworthy due to its reactivity and ability to form disulfide bonds. This feature has been exploited in the design of bioconjugates and drug delivery systems, where the thiol can serve as a site for covalent attachment to biomolecules. Additionally, the sulfur atom's ability to participate in redox reactions makes this compound an attractive candidate for studying redox-sensitive signaling pathways in cells.

In vitro studies have begun to explore the pharmacological profile of 5-(5-Methyl-2-furyl)-1,2,4-triazine-3-thiol, revealing interesting interactions with biological molecules. Preliminary data suggest that this compound may modulate the activity of enzymes such as kinases and phosphodiesterases, which are critical targets in oncology and inflammatory diseases. The furyl substituent's electronic properties have also been found to enhance binding affinity to certain protein pockets, suggesting its utility in designing high-affinity ligands.

The synthesis of 5-(5-Methyl-2-furyl)-1,2,4-triazine-3-thiol presents both challenges and opportunities for chemists. Traditional synthetic routes involve multi-step processes that require careful optimization to ensure high yield and purity. However, recent innovations in catalytic methods have streamlined the synthesis of heterocyclic compounds like this one, making it more accessible for large-scale production. These advancements are particularly important for enabling further exploration of its biological activities.

Future research directions for 5-(5-Methyl-2-furyl)-1,2,4-triazine-3-thiol include exploring its potential as an intermediate in drug development pipelines. By leveraging its structural features, researchers aim to create novel derivatives with enhanced pharmacological properties. Additionally, investigating its behavior in complex biological systems will provide insights into how it interacts with cellular machinery and whether it can be leveraged for therapeutic interventions.

The growing interest in 5-(5-Methyl-2-furyl)-1,2,4-triazine-3-thiol underscores the importance of heterocyclic compounds in modern medicinal chemistry. As our understanding of molecular interactions continues to evolve, compounds like this one will play an increasingly significant role in addressing complex diseases. The combination of computational modeling, synthetic chemistry, and biological testing will be essential in unlocking their full potential.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)